Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 20Uterine Cervical Neoplasms 19Endometrial Neoplasms 9Stomach Neoplasms 8Melanoma 8Carcinoma, Renal Cell 8Squamous Cell Carcinoma of Head and Neck 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Fallopian Tube Neoplasms 6Carcinoma, Hepatocellular 6Breast Neoplasms 6Pancreatic Neoplasms 5Carcinoma, Transitional Cell 5Triple Negative Breast Neoplasms 4Neoplasms 4Neoplasm Metastasis 4Head and Neck Neoplasms 4Esophageal Neoplasms 4Carcinoma, Merkel Cell 4Small Cell Lung Carcinoma 3Prostatic Neoplasms 3Sarcoma 2Recurrence 2Microsatellite Instability 2Lymphoma 2Kidney Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma 2Vulvar Neoplasms 1

Interventions

rocakinogene sifuplasmid 1pembrolizumab 1durvalumab 1atezolizumab 1Vaccines 1VGX-3100 1Magnetic Resonance Spectroscopy 1MEDI0457 1Immunoglobulin G 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anal Canal Carcinoma × atezolizumab × Gynecologic × Clear all
NCT03946358 2024-12-20

VolATIL

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed
47 enrolled
GastrointestinalGynecologicHead & Neck

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡